Penn’s Perelman School of Medicine launched Coronavirus research center
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
-
-
Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and sell the assay in Europe
On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and…
-
Vir Biotech proceeded with two clinical development candidates for COVID-19
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
-
Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
-
Resverlogix clinical candidate apabetalone featured as potential COVID-19 treatment in publication
On Mar. 24, 2020, Resverlogix announced a Mar. 23, 2020 bioRxiv publication that has shown apabetalone to inhibit…
-
COVID-19 | Diagnostics | FDA
FDA provided Emergency Use Authorization to PerkinElmer for COVID-19 testing
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
-
Biotechnology | COVID-19 | Diagnostics | FDA
bioMerieux received FDA Emergency Use Authorization for BIOFIRE COVID-19 test
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
-
Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point ofcCare molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for…
-
Resverlogix invited collaborations for use of Apabetalone in trials and studies to Combat spread of COVID-19
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
-
Sorrento and SmartPharm Therapeutics announced research and development collaboration develop a next-generation, gene-encoded antibody vaccine for COVID-19
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
-
serum therapy used as possible COVID-19 treatment
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
-
Philips ramped up production of critical health technology products in response to COVID-19 pandemic
On Mar. 22, 2020, Royal Philips announced that it is increasing the production of certain critical care products and…
-
Quest Diagnostics dedicated special hours for non-COVID-19 testing for older and Highly vulnerable patients
On Mar. 21, 2020, through its “Peace of Mind” program, Quest Diagnostics took extra measures to ensure individuals…
-
Chembio Diagnostics received $4 million purchase order from Bio-Manguinhos for production of DPP COVID-19 IgM/IgG system in Brazil
On Mar. 20, 2020, Chembio Diagnostics announced receipt of a $4 million order from Bio-Manguinhos for the purchase…
-
BioReference Laboratories and State of New Jersey provided testing for Coronavirus 2019
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
-
Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
-
PRA Health Sciences launches COVID-19 monitoring program
On Mar. 20, 2020, PRA Health Sciences announced the commercial availability of the COVID-19 Monitoring Program, a mobile…
-
FDA granted Bellerophon emergency expanded access for INOpulse for treatment of COVID-19 virus
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
-
Abbott received FDA Emergency Use Authorization and launches test to detect novel Coronavirus
On Mar. 19, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA)…
-
Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
-
Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
On Mar. 19, 2020, Mesa Biotech announced it has significantly expanded its capacity to test clinical samples for…
-
LabCorp sets dedicated hours to serve the non-COVID-19 testing needs for elderly and most vulnerable people
On Mar. 19, 2020, LabCorp announced it is dedicating the first hour of service each day at its…
-
Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
-
iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
-
Todos Medical signed novel Coronavirus (COVID-19) point-of-care rapid antibody testing kit exclusive distribution agreement
On Mar. 19, 2020, Todos Medical announced it had entered into an exclusive distribution agreement for the U.S….
-
UC Davis researchers raced to develop coronavirus solutions
On Mar. 19, 2020, Clinical pathologists, infectious disease physicians and scientists at the UC Davis Medical Center, California…
-
Heat Biologics collaborated with University of Miami to develop COVID-19 Coronavirus vaccine
On Mar. 18, 2020, Immunology researchers at the University of Miami Miller School of Medicine announced a collaboration…
-
Edmonton company Entos Pharma developing DNA vaccine against COVID-19
On Mar. 18, 2020, Entos Pharmaceuticals, a health-care biotechnology company that develops new therapeutic compounds using the company’s…
-
Oxford scientists developed rapid testing technology for COVID-19
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
-
Abbott received FDA Emergency Use Authorization and launched test to detect novel Coronavirus
On Mar. 18, 2020, Abbott announced that the the U.S. Food and Drug Administration had issued Emergency Use…
